Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up

PURPOSE: The Occlutech Figulla occluder has been proven safe and effective at midterm follow-up after percutaneous atrial septal defect (ASD) closure. We describe the safety and efficacy at long-term follow-up in adults. METHODS: All consecutive adult patients that underwent ASD closure between 2008...

Descripción completa

Detalles Bibliográficos
Autores principales: Snijder, R. J. R., Renes, L. E., Bosshardt, D., Suttorp, M. J., ten Berg, J. M., Post, M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042503/
https://www.ncbi.nlm.nih.gov/pubmed/32140088
http://dx.doi.org/10.1155/2020/7136802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042503/
https://www.ncbi.nlm.nih.gov/pubmed/32140088
http://dx.doi.org/10.1155/2020/7136802

Ejemplares similares